• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Timmy, Belgium

    Timmy, Belgium

  • Jay Epstein, USA

    Jay Epstein, USA

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Zabun Nassar, England

    Zabun Nassar, England

  • Ali Var, Turkey

    Ali Var, Turkey

  • Dick Dayton, USA

    Dick Dayton, USA

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Animesh Kumar, India

    Animesh Kumar, India

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Ian Gale, Australia

    Ian Gale, Australia

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Susan Keldani, USA

    Susan Keldani, USA

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Frank Taylor, USA

    Frank Taylor, USA

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Liam Dwyer, England

    Liam Dwyer, England

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • David Hall, USA

    David Hall, USA

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • JP

    JP

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Rob Tison, USA

    Rob Tison, USA

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Jean

    Jean
    jean

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • David Watson, Scotland

    David Watson, Scotland

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login